The next step for taribavirin
โ
Paul Y. Kwo; Rakesh Vinayek
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 143 KB
Dr. Kwo advises, is on the speakers' bureau of, and received grants from Merck and Gilead. He advises and received grants from Vertex, Abbott, and Human Genome Sciences. He advises Novartis and Anadys. He is on the speakers' bureau of Roche and Bristol-Myers Squibb. He advises and is on the speakers